U.S. Markets closed

Urologix, Inc. (ULGX)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.00128-0.00032 (-20.00000%)
At close: 1:36PM EDT
People also watch
VASCIRIXUTMDSPNCSTAA
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Revenue6/30/20146/30/20136/30/2012
Total Revenue14,23516,59017,027
Cost of Revenue8,1428,4078,645
Gross Profit6,0938,1838,382
Operating Expenses
Research Development1,6252,2692,189
Selling General and Administrative8,2679,89310,248
Non Recurring3,036160160
Others9510490
Total Operating Expenses13,02312,426-
Operating Income or Loss-6,930-3,922-4,145
Income from Continuing Operations
Total Other Income/Expenses Net-1520-13
Earnings Before Interest and Taxes-7,624-4,278-4,640
Interest Expense---
Income Before Tax-7,624-4,278-4,640
Income Tax Expense-161455
Minority Interest---
Net Income From Continuing Ops-7,608-4,086-4,695
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-7,608-4,292-4,695
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-7,608-4,292-4,695